SCHEMBL4027409

SCHEMBL4027409

O=C(NCc1ccc(F)c(F)c1)C1CCNCC1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
ERCC1 P07992 2/20 0.52
ERCC4 Q92889 2/20 0.52
HTR2C P28335 1/20 0.52
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
HPGD P15428 2/20 0.47
USP2 O75604 1/20 0.47
MCHR1 Q99705 1/20 0.46
EPHX2 P34913 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALOX15 P16050 1/20 0.45
P2RX7 Q99572 1/20 0.45
SLC13A5 Q86YT5 1/20 0.45
TSHR P16473 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31377773 0.92 HTR2C (0.62) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
SCHEMBL4037264 0.85 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
SCHEMBL12101966 0.84 ERCC1 (0.51) ALDH1A1SMN1; SMN2ERCC1ERCC4HPGD
Hydrochloric Acid SCHEMBL6479155 0.84 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
SCHEMBL172079 0.82 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CCHRM1CHRM3
SCHEMBL25156178 0.82 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
SCHEMBL29583269 0.82 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
Hydrochloric Acid SCHEMBL30164247 0.81 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HTR2CCHRM1CHRM3
SCHEMBL4003149 0.81 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C
SCHEMBL30298669 0.80 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2ERCC1ERCC4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed